| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.53e-06 | 51 | 77 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.24e-06 | 55 | 77 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.46e-06 | 60 | 77 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.27e-05 | 78 | 77 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.65e-05 | 102 | 77 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 5.10e-05 | 104 | 77 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.23e-04 | 66 | 77 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.23e-04 | 66 | 77 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | dATP binding | 1.46e-04 | 5 | 77 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.46e-04 | 5 | 77 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 2.18e-04 | 6 | 77 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.56e-04 | 229 | 77 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 3.04e-04 | 7 | 77 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 4.56e-04 | 39 | 77 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 5.19e-04 | 9 | 77 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 5.19e-04 | 9 | 77 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 6.47e-04 | 10 | 77 | 2 | GO:0030235 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.55e-03 | 441 | 77 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.11e-03 | 739 | 77 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.16e-03 | 18 | 77 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | RNA methyltransferase activity | 2.21e-03 | 67 | 77 | 3 | GO:0008173 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.27e-03 | 238 | 77 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 2.31e-03 | 68 | 77 | 3 | GO:0140223 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B SETX DNAH12 SMARCAD1 DNAH8 DDX11L8 HSP90AA1 HSP90AA2P | 2.49e-03 | 614 | 77 | 8 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.51e-03 | 70 | 77 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B DNAH12 GBP4 SMARCAD1 RAB20 DNAH8 DDX11L8 HSP90AA1 HSP90AA2P | 2.91e-03 | 775 | 77 | 9 | GO:0017111 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.94e-03 | 21 | 77 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 3.37e-03 | 645 | 77 | 8 | GO:0140640 | |
| GeneOntologyMolecularFunction | S-adenosyl-L-methionine binding | 3.52e-03 | 23 | 77 | 2 | GO:1904047 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 4.96e-05 | 254 | 78 | 7 | GO:0071826 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 6.20e-05 | 358 | 78 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 6.20e-05 | 358 | 78 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 6.70e-05 | 362 | 78 | 8 | GO:0000375 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF21B CACNA1S DLGAP2 HAUS6 FBN1 DNAH12 PNN NCKIPSD CKAP5 DIAPH1 TMOD4 MAP10 DNAH8 FBN3 | 1.05e-04 | 1179 | 78 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF21B CACNA1S DLGAP2 HAUS6 FBN1 DNAH12 PNN NCKIPSD CKAP5 DIAPH1 TMOD4 MAP10 DNAH8 FBN3 | 1.13e-04 | 1187 | 78 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | spindle | 3.69e-04 | 471 | 78 | 8 | GO:0005819 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 4.78e-04 | 97 | 78 | 4 | GO:0071013 | |
| MousePheno | long ribs | 1.87e-05 | 2 | 61 | 2 | MP:0004671 | |
| Domain | TAF_II_230-bd | 1.55e-05 | 2 | 74 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 1.55e-05 | 2 | 74 | 2 | IPR022591 | |
| Domain | - | 1.55e-05 | 2 | 74 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 1.55e-05 | 2 | 74 | 2 | PF09247 | |
| Domain | DUF3591 | 1.55e-05 | 2 | 74 | 2 | PF12157 | |
| Domain | TAF1_animal | 1.55e-05 | 2 | 74 | 2 | IPR011177 | |
| Domain | FBN | 4.63e-05 | 3 | 74 | 2 | IPR011398 | |
| Domain | UIM | 1.14e-04 | 24 | 74 | 3 | PS50330 | |
| Domain | UIM_dom | 1.29e-04 | 25 | 74 | 3 | IPR003903 | |
| Domain | TB | 3.21e-04 | 7 | 74 | 2 | PF00683 | |
| Domain | - | 4.27e-04 | 8 | 74 | 2 | 3.90.290.10 | |
| Domain | TB | 5.48e-04 | 9 | 74 | 2 | PS51364 | |
| Domain | TB_dom | 5.48e-04 | 9 | 74 | 2 | IPR017878 | |
| Domain | WWE | 9.96e-04 | 12 | 74 | 2 | PS50918 | |
| Domain | WWE | 9.96e-04 | 12 | 74 | 2 | PF02825 | |
| Domain | WWE-dom | 9.96e-04 | 12 | 74 | 2 | IPR004170 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.37e-03 | 14 | 74 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.37e-03 | 14 | 74 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.37e-03 | 14 | 74 | 2 | PF08393 | |
| Domain | AAA_8 | 1.37e-03 | 14 | 74 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.37e-03 | 14 | 74 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.37e-03 | 14 | 74 | 2 | PF07728 | |
| Domain | DHC_fam | 1.57e-03 | 15 | 74 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.57e-03 | 15 | 74 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.57e-03 | 15 | 74 | 2 | PF03028 | |
| Domain | ARM-type_fold | 2.25e-03 | 339 | 74 | 6 | IPR016024 | |
| Domain | UIM | 2.27e-03 | 18 | 74 | 2 | PF02809 | |
| Domain | UIM | 3.10e-03 | 21 | 74 | 2 | SM00726 | |
| Domain | ARM-like | 4.35e-03 | 270 | 74 | 5 | IPR011989 | |
| Domain | Integrin_dom | 4.38e-03 | 25 | 74 | 2 | IPR032695 | |
| Domain | cEGF | 4.73e-03 | 26 | 74 | 2 | IPR026823 | |
| Domain | cEGF | 4.73e-03 | 26 | 74 | 2 | PF12662 | |
| Domain | Bromodomain_CS | 4.73e-03 | 26 | 74 | 2 | IPR018359 | |
| Pathway | PID_ILK_PATHWAY | 4.14e-05 | 45 | 61 | 4 | M71 | |
| Pathway | WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE | 5.02e-05 | 17 | 61 | 3 | M39733 | |
| Pathway | BIOCARTA_LAIR_PATHWAY | 5.02e-05 | 17 | 61 | 3 | M3952 | |
| Pathway | BIOCARTA_P53HYPOXIA_PATHWAY | 9.70e-05 | 21 | 61 | 3 | M5202 | |
| Pubmed | Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinase. | 4.33e-08 | 4 | 78 | 3 | 21767636 | |
| Pubmed | 2.40e-07 | 24 | 78 | 4 | 34983926 | ||
| Pubmed | 2.85e-07 | 288 | 78 | 8 | 23383273 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.32e-07 | 332 | 78 | 8 | 32786267 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP14 FAM120B SETX PNN POLE CKAP5 DIAPH1 CTNNBL1 TFIP11 SMARCAD1 SCFD1 HUWE1 GTF3C3 HSP90AA1 | 1.70e-06 | 1353 | 78 | 14 | 29467282 |
| Pubmed | USP14 NCOA3 KHDRBS1 PNN POLE CENPH DIAPH1 CTNNBL1 SMARCAD1 TAF1 GTF3C3 HSP90AA1 | 2.62e-06 | 1014 | 78 | 12 | 32416067 | |
| Pubmed | 2.75e-06 | 390 | 78 | 8 | 17643375 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18549652 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 38804708 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22842574 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27571988 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34403156 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 26523394 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25714412 | ||
| Pubmed | The PI3K and AIB1 interaction is involved in estrogen treated breast cancer cells. | 4.97e-06 | 2 | 78 | 2 | 29808803 | |
| Pubmed | Integrin-mediated long-term B cell retention in the splenic marginal zone. | 4.97e-06 | 2 | 78 | 2 | 12130787 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15221638 | ||
| Pubmed | Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene. | 4.97e-06 | 2 | 78 | 2 | 2591742 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12121438 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10070062 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20585984 | ||
| Pubmed | NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. | 4.97e-06 | 2 | 78 | 2 | 17805331 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 5.84e-06 | 736 | 78 | 10 | 29676528 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 6.33e-06 | 582 | 78 | 9 | 20467437 | |
| Pubmed | 8.45e-06 | 57 | 78 | 4 | 18022353 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FBXO38 NCOA3 PNN CKAP5 TFIP11 SCAF11 SMARCAD1 SCFD1 HUWE1 OGA | 9.05e-06 | 774 | 78 | 10 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SNRPGP15 SETX KHDRBS1 PNN BCORL1 TFIP11 SCAF11 TAF1 TAF1L SNRPG HSP90AA1 | 9.09e-06 | 954 | 78 | 11 | 36373674 |
| Pubmed | 9.23e-06 | 215 | 78 | 6 | 35973513 | ||
| Pubmed | 1.06e-05 | 469 | 78 | 8 | 27634302 | ||
| Pubmed | 1.20e-05 | 20 | 78 | 3 | 22504172 | ||
| Pubmed | 1.32e-05 | 638 | 78 | 9 | 33239621 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 29139175 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 10995457 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 20937816 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 17379071 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 34333223 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 12586360 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 22213475 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 18593948 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 16822332 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 23047954 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19662498 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 37633951 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 15146192 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 23511556 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19136058 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 1.49e-05 | 3 | 78 | 2 | 11592977 | |
| Pubmed | Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha. | 1.49e-05 | 3 | 78 | 2 | 12446770 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 1.49e-05 | 3 | 78 | 2 | 16407123 | |
| Pubmed | HAX-1 Protects Glioblastoma Cells from Apoptosis through the Akt1 Pathway. | 1.49e-05 | 3 | 78 | 2 | 29311840 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 8020569 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 11425855 | ||
| Pubmed | The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha. | 2.97e-05 | 4 | 78 | 2 | 19234166 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 21177334 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 2.97e-05 | 4 | 78 | 2 | 25034023 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 23065523 | ||
| Pubmed | Mapping of the gene family for human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. | 2.97e-05 | 4 | 78 | 2 | 1740332 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 9452498 | ||
| Pubmed | Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. | 2.97e-05 | 4 | 78 | 2 | 15782121 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 23589305 | ||
| Pubmed | Specific phosphorylations transmit signals from leukocyte β2 to β1 integrins and regulate adhesion. | 2.97e-05 | 4 | 78 | 2 | 25278023 | |
| Pubmed | EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. | 2.97e-05 | 4 | 78 | 2 | 22314363 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 12163503 | ||
| Pubmed | A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links. | 2.97e-05 | 4 | 78 | 2 | 29968717 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 17553614 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 27184401 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 19353432 | ||
| Pubmed | 3.26e-05 | 549 | 78 | 8 | 38280479 | ||
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 3.94e-05 | 84 | 78 | 4 | 26299517 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.33e-05 | 283 | 78 | 6 | 30585729 | |
| Pubmed | 4.37e-05 | 418 | 78 | 7 | 34709266 | ||
| Pubmed | RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 integrins. | 4.94e-05 | 5 | 78 | 2 | 21705617 | |
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 15843522 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 19778379 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 9421166 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 18566586 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 24126057 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 15090462 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 24006483 | ||
| Pubmed | Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding. | 4.94e-05 | 5 | 78 | 2 | 29021135 | |
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 12171996 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 19197339 | ||
| Pubmed | Akt and CHIP coregulate tau degradation through coordinated interactions. | 4.94e-05 | 5 | 78 | 2 | 18292230 | |
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 12097820 | ||
| Pubmed | Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. | 4.94e-05 | 5 | 78 | 2 | 16844778 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.28e-05 | 588 | 78 | 8 | 38580884 | |
| Pubmed | HAUS6 PPP2R3A SETX FRMD6 SCFD1 HUWE1 SLC39A14 GTF3C3 HSP90AA1 | 6.10e-05 | 777 | 78 | 9 | 35844135 | |
| Pubmed | NCOA3 KHDRBS1 CKAP5 CTNNBL1 AKT1 HUWE1 USP37 ST13 GTF3C3 HSP90AA1 | 6.21e-05 | 971 | 78 | 10 | 33306668 | |
| Pubmed | 6.37e-05 | 604 | 78 | 8 | 38803224 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.67e-05 | 608 | 78 | 8 | 36089195 | |
| Pubmed | 7.04e-05 | 451 | 78 | 7 | 30033366 | ||
| Pubmed | Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes. | 7.40e-05 | 6 | 78 | 2 | 17324930 | |
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 12176997 | ||
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 19959467 | ||
| Pubmed | Threonine phosphorylation sites in the beta 2 and beta 7 leukocyte integrin polypeptides. | 7.40e-05 | 6 | 78 | 2 | 12682249 | |
| Pubmed | MOZ increases p53 acetylation and premature senescence through its complex formation with PML. | 7.40e-05 | 6 | 78 | 2 | 23431171 | |
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 26414348 | ||
| Pubmed | Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect. | 1.04e-04 | 7 | 78 | 2 | 19356729 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 9765275 | ||
| Interaction | SNRNP200 interactions | USP14 KHDRBS1 KAT6A CTNNBL1 TFIP11 HUWE1 ITGA4 USP37 SNRPG GTF3C3 HSP90AA1 TIPARP | 1.93e-07 | 460 | 78 | 12 | int:SNRNP200 |
| Interaction | TOP1 interactions | USP14 KHDRBS1 PNN ASXL3 POLE KAT6A CKAP5 DIAPH1 CTNNBL1 SCAF11 ITGA4 SNRPG GTF3C3 TIPARP | 3.99e-07 | 696 | 78 | 14 | int:TOP1 |
| Interaction | PELO interactions | 2.99e-06 | 161 | 78 | 7 | int:PELO | |
| Interaction | PRPF19 interactions | PNN KAT6A PKHD1 CTNNBL1 TFIP11 SMARCAD1 HUWE1 USP37 SNRPG HSP90AA1 | 9.04e-06 | 450 | 78 | 10 | int:PRPF19 |
| Interaction | SNW1 interactions | KHDRBS1 PNN POLE CKAP5 DIAPH1 CTNNBL1 TFIP11 SMARCAD1 HUWE1 SNRPG HSP90AA1 TIPARP | 2.83e-05 | 747 | 78 | 12 | int:SNW1 |
| Interaction | SNRNP40 interactions | USP14 SETX KHDRBS1 PNN KAT6A CTNNBL1 TFIP11 SCAF11 SMARCAD1 USP37 SNRPG | 3.28e-05 | 637 | 78 | 11 | int:SNRNP40 |
| Interaction | U2AF2 interactions | USP14 KHDRBS1 PNN CTNNBL1 TFIP11 SCAF11 SMARCAD1 HUWE1 SNRPG ST13 HSP90AA1 | 4.00e-05 | 651 | 78 | 11 | int:U2AF2 |
| Interaction | SNRPC interactions | SNRPGP15 KHDRBS1 PNN NCKIPSD CTNNBL1 TFIP11 SCAF11 SNRPG TIPARP | 5.00e-05 | 440 | 78 | 9 | int:SNRPC |
| Interaction | SF3A3 interactions | 5.08e-05 | 340 | 78 | 8 | int:SF3A3 | |
| Interaction | XRCC6 interactions | USP14 ASXL3 DIAPH1 TFIP11 SCAF11 SMARCAD1 TAF1 HUWE1 ITGA4 TAF1L ST13 HSP90AA1 TIPARP | 5.27e-05 | 928 | 78 | 13 | int:XRCC6 |
| Interaction | SSRP1 interactions | USP14 SETX KHDRBS1 PNN POLE KAT6A SCAF11 SMARCAD1 HUWE1 ITGA4 TIPARP | 6.33e-05 | 685 | 78 | 11 | int:SSRP1 |
| Interaction | CRNKL1 interactions | 6.42e-05 | 177 | 78 | 6 | int:CRNKL1 | |
| Interaction | CDK1 interactions | USP14 KHDRBS1 ASXL3 POLE KAT6A CKAP5 AKT1 HUWE1 ITGA4 HSP90AA1 | 9.01e-05 | 590 | 78 | 10 | int:CDK1 |
| Interaction | WASL interactions | 9.11e-05 | 117 | 78 | 5 | int:WASL | |
| Interaction | HNRNPK interactions | USP14 KHDRBS1 KAT6A CKAP5 DIAPH1 CTNNBL1 SMARCAD1 HUWE1 ITGA4 SNRPG HSP90AA1 TIPARP | 1.01e-04 | 853 | 78 | 12 | int:HNRNPK |
| Interaction | CLK2 interactions | 1.09e-04 | 195 | 78 | 6 | int:CLK2 | |
| Interaction | USP7 interactions | FBXO38 USP14 SFRP4 FBN1 KHDRBS1 PNN BCORL1 FTSJ1 TFIP11 SMARCAD1 TAF1 HUWE1 OVCH1 ST13 TIPARP | 1.33e-04 | 1313 | 78 | 15 | int:USP7 |
| Interaction | OGA interactions | 1.44e-04 | 129 | 78 | 5 | int:OGA | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.56e-06 | 17 | 45 | 3 | 486 | |
| GeneFamily | Dyneins, axonemal | 8.04e-04 | 17 | 45 | 2 | 536 | |
| Coexpression | ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT | 1.07e-05 | 97 | 78 | 5 | M39213 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 2.90e-05 | 199 | 78 | 6 | M5726 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 2.90e-05 | 199 | 78 | 6 | M4444 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN | 2.98e-05 | 200 | 78 | 6 | M6601 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP | 2.98e-05 | 200 | 78 | 6 | M4332 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | HAUS6 SETX PNN POLE CENPH BCORL1 CKAP5 SCAF11 SMARCAD1 USP37 | 1.53e-05 | 532 | 74 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | EPHB3 HAUS6 SETX PNN ASXL3 POLE CENPH CKAP5 TMOD4 SCAF11 SMARCAD1 KCNAB3 SNRPG HSP90AA1 TIPARP | 2.04e-05 | 1241 | 74 | 15 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | HAUS6 FRY SETX GBP4 KHDRBS1 PNN SLC38A4 ASXL3 RDH10 ADGRF5 ITGA4 USP37 | 3.01e-05 | 837 | 74 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | EPHB3 HAUS6 SETX PNN ASXL3 POLE CENPH CKAP5 TMOD4 SCAF11 SMARCAD1 ITGA4 KCNAB3 SNRPG HSP90AA1 TIPARP | 3.67e-05 | 1468 | 74 | 16 | facebase_RNAseq_e10.5_MandArch_2500 |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-08 | 200 | 78 | 7 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.15e-07 | 178 | 78 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.24e-07 | 186 | 78 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.33e-06 | 198 | 78 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.33e-06 | 198 | 78 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.33e-06 | 198 | 78 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 200 | 78 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.41e-06 | 200 | 78 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.09e-06 | 156 | 78 | 5 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.09e-06 | 156 | 78 | 5 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.09e-06 | 156 | 78 | 5 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 166 | 78 | 5 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 184 | 78 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.99e-05 | 188 | 78 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-05 | 190 | 78 | 5 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.26e-05 | 193 | 78 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| Drug | NSC 255110 | 9.98e-06 | 13 | 76 | 3 | CID000318505 | |
| Drug | 2qfo | 1.10e-05 | 2 | 76 | 2 | CID000600769 | |
| Drug | 3-amino-5-chlorobenzoic acid | 1.10e-05 | 2 | 76 | 2 | CID010986726 | |
| Drug | 3eko | 1.10e-05 | 2 | 76 | 2 | CID011160307 | |
| Drug | monocillin III | 1.10e-05 | 2 | 76 | 2 | CID006478910 | |
| Drug | pochonin A | 1.10e-05 | 2 | 76 | 2 | CID006478909 | |
| Drug | 1uyi | 1.10e-05 | 2 | 76 | 2 | CID005289232 | |
| Drug | PU-H71 | 1.10e-05 | 2 | 76 | 2 | CID009549213 | |
| Drug | NSC683666 | 1.10e-05 | 2 | 76 | 2 | CID005469153 | |
| Drug | H 64 | 1.10e-05 | 2 | 76 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 1.10e-05 | 2 | 76 | 2 | CID015942101 | |
| Drug | 1uyc | 1.10e-05 | 2 | 76 | 2 | CID000448969 | |
| Drug | PU-9 | 1.10e-05 | 2 | 76 | 2 | CID000448971 | |
| Drug | P u 0 | 1.10e-05 | 2 | 76 | 2 | CID000448974 | |
| Drug | 2qf6 | 1.10e-05 | 2 | 76 | 2 | CID013373715 | |
| Drug | CHEBI:42139 | 1.10e-05 | 2 | 76 | 2 | CID011562562 | |
| Drug | Mfpa | 3.29e-05 | 3 | 76 | 2 | CID003035615 | |
| Drug | pochonin D | 3.29e-05 | 3 | 76 | 2 | CID006478913 | |
| Drug | azaquinone | 3.29e-05 | 3 | 76 | 2 | CID000099132 | |
| Drug | d 1 v | 3.29e-05 | 3 | 76 | 2 | CID000683940 | |
| Drug | HM-9 | 3.29e-05 | 3 | 76 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 3.29e-05 | 3 | 76 | 2 | CID000133564 | |
| Drug | AC1MD0RC | 3.29e-05 | 3 | 76 | 2 | CID002829073 | |
| Drug | CL-387,785 | 3.91e-05 | 20 | 76 | 3 | CID000002776 | |
| Drug | CGP7040 | 3.91e-05 | 20 | 76 | 3 | CID006436259 | |
| Drug | NCI60_002052 | 3.91e-05 | 20 | 76 | 3 | CID006801032 | |
| Drug | wedelolactone | 3.91e-05 | 20 | 76 | 3 | CID005281813 | |
| Drug | UCS15A | 4.55e-05 | 21 | 76 | 3 | CID005311041 | |
| Drug | Ab-9 | 4.55e-05 | 21 | 76 | 3 | CID006540280 | |
| Drug | O-Su | 4.85e-05 | 60 | 76 | 4 | CID000447970 | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 1695_DN | |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; HL60; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 2924_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 4392_UP | |
| Drug | Neriolin | 6.03e-05 | 23 | 76 | 3 | CID000010057 | |
| Drug | cruentaren A | 6.57e-05 | 4 | 76 | 2 | ctd:C516694 | |
| Drug | uranyl chloride | 6.57e-05 | 4 | 76 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 6.57e-05 | 4 | 76 | 2 | CID000069988 | |
| Drug | 11p110 | 6.57e-05 | 4 | 76 | 2 | CID002382787 | |
| Drug | fenthion | 6.88e-05 | 24 | 76 | 3 | CID000003346 | |
| Drug | vorinostat | 8.60e-05 | 314 | 76 | 7 | CID000005311 | |
| Drug | KNK437 | 8.79e-05 | 26 | 76 | 3 | CID009859662 | |
| Drug | AC1L1G9T | 9.77e-05 | 433 | 76 | 8 | CID000003591 | |
| Drug | 1uy7 | 1.09e-04 | 5 | 76 | 2 | CID005289227 | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 1.09e-04 | 5 | 76 | 2 | ctd:C001079 | |
| Drug | 1uyd | 1.09e-04 | 5 | 76 | 2 | CID000448970 | |
| Drug | Org 31806 | 1.09e-04 | 5 | 76 | 2 | CID000164147 | |
| Drug | CRT0044876 | 1.09e-04 | 5 | 76 | 2 | CID000081409 | |
| Drug | HCV-796 | 1.09e-04 | 5 | 76 | 2 | CID011561383 | |
| Drug | chaetochromin | 1.09e-04 | 5 | 76 | 2 | CID000053277 | |
| Drug | 1,1-diphenyl-2-propyn-1-ol | 1.09e-04 | 5 | 76 | 2 | CID000092976 | |
| Drug | 4-hydroxyestradiol | 1.42e-04 | 79 | 76 | 4 | CID000001743 | |
| Drug | AC1L8SKE | 1.50e-04 | 31 | 76 | 3 | CID000386852 | |
| Drug | Hantzsch ester | 1.64e-04 | 6 | 76 | 2 | CID000070849 | |
| Drug | 3-aminocoumarin | 1.64e-04 | 6 | 76 | 2 | CID000074217 | |
| Drug | Pu x | 1.64e-04 | 6 | 76 | 2 | CID000448976 | |
| Drug | oxygen anion | 1.64e-04 | 6 | 76 | 2 | CID005460641 | |
| Drug | 15-deoxyspergualin | 1.65e-04 | 32 | 76 | 3 | CID000055361 | |
| Drug | SureCN1562346 | 1.81e-04 | 33 | 76 | 3 | CID011646228 | |
| Drug | 17-aminogeldanamycin | 2.28e-04 | 7 | 76 | 2 | CID000429444 | |
| Drug | Nepl | 2.28e-04 | 7 | 76 | 2 | CID006439214 | |
| Drug | NSC330499 | 2.28e-04 | 7 | 76 | 2 | CID000433447 | |
| Drug | 1,2,4,7,8-pentachlorodibenzo-p-dioxin | 2.28e-04 | 7 | 76 | 2 | CID000042836 | |
| Drug | Zlll-mca | 2.28e-04 | 7 | 76 | 2 | CID000132936 | |
| Drug | dienochlor | 2.28e-04 | 7 | 76 | 2 | CID000016686 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.36e-04 | 166 | 76 | 5 | 1066_UP | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 2.43e-04 | 167 | 76 | 5 | 6187_UP | |
| Drug | eupatilin | 2.77e-04 | 38 | 76 | 3 | CID005273755 | |
| Drug | Murametide | 3.04e-04 | 8 | 76 | 2 | CID000133276 | |
| Drug | phenyldichloroarsine | 3.04e-04 | 8 | 76 | 2 | CID000012762 | |
| Drug | GGMP | 3.04e-04 | 8 | 76 | 2 | CID006443839 | |
| Drug | D-box | 3.04e-04 | 8 | 76 | 2 | CID000133881 | |
| Drug | 9-phenanthrol | 3.04e-04 | 8 | 76 | 2 | CID000010229 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.96e-05 | 3 | 76 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 6.82e-05 | 268 | 76 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 1.93e-04 | 619 | 76 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | nephritis (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | pneumonia (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 3.71e-04 | 54 | 76 | 3 | C0149925 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 5.01e-04 | 13 | 76 | 2 | C3501611 | |
| Disease | T-Cell Lymphoma | 7.67e-04 | 16 | 76 | 2 | C0079772 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 7.67e-04 | 16 | 76 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Child Behaviour Checklist assessment | 9.75e-04 | 18 | 76 | 2 | EFO_0005661 | |
| Disease | Adenocarcinoma of large intestine | 1.98e-03 | 96 | 76 | 3 | C1319315 | |
| Disease | Heart valve disease | 2.04e-03 | 26 | 76 | 2 | C0018824 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MITITPPDQDDSMEC | 446 | P31749 | |
| IVENMAEFRPEMCTE | 221 | Q8WYA6 | |
| AMDQDEEEQTVLTPM | 961 | Q9NZJ5 | |
| QLEREMASPPECSEM | 606 | Q5H9F3 | |
| QDDECIPMMTPSDIT | 581 | Q9P1A6 | |
| DEMQCSPEEMQVLRP | 541 | Q8N6M6 | |
| QPEDMNERVLEAMTE | 271 | O60610 | |
| MMTCEDIDECSLNPL | 2161 | Q75N90 | |
| QIAPPEDNLESCVMM | 491 | Q9C0F0 | |
| PQEMGDENAEITEEM | 96 | P50502 | |
| VPCMESIMTEDRLNE | 1226 | Q68CQ1 | |
| MLDEQDVPAAEQMCF | 166 | Q9NX57 | |
| PCEAVLEMDAERMGE | 76 | A6NCS4 | |
| MEMETTEPEPDCVVQ | 1 | Q7Z3E1 | |
| QTRPALDMCQEMEQL | 181 | C9J442 | |
| ITIEPQMNAPEEMDD | 321 | Q9P2G4 | |
| SQPEEVMDVLEMVEN | 381 | Q9H307 | |
| LMMVVTGDEDENSPC | 16 | Q96S96 | |
| DMTEAHMPCVQVEAN | 1001 | Q6ZU69 | |
| DNEIQMDMTLGPIEE | 1131 | Q96JB1 | |
| MRMCTQPDLVNEAVT | 236 | O75037 | |
| EPIFCSEDIMQQMPE | 916 | Q6ZR08 | |
| PVMILTEFMENCALD | 706 | P54753 | |
| IMMAPICLVENQEEQ | 21 | Q96PP9 | |
| PEDMCRMATEQPQTL | 441 | Q07864 | |
| SMCSLCQEENEDMVP | 91 | Q3KNT7 | |
| MEDCKEQEPIMDNNI | 241 | Q9UKS7 | |
| METDMDGVQCIPQRA | 491 | Q7Z6Z7 | |
| YEEQCERMEAMGIEP | 1001 | Q06190 | |
| CIMNNEIPEEMTADE | 11 | Q6PIJ6 | |
| GLDAMMQVAACPEEI | 236 | P05107 | |
| QADEDPQMSMVEDCH | 1461 | Q92794 | |
| EQMNEESLEVSPDMC | 466 | Q96NE9 | |
| AVELMDRTEMPCQAL | 626 | Q14008 | |
| RVKCMANEVMEDPGQ | 926 | Q711Q0 | |
| EANPPFCEELMDAMV | 551 | Q9H4Z3 | |
| MEEQPQMQDADEPAD | 1 | Q9H3R5 | |
| MENNGQPCINDDEEM | 616 | P13671 | |
| DACQMEPEEVEIMAT | 1816 | Q13698 | |
| MMTCEDINECAQNPL | 2201 | P35555 | |
| DLPQMMDEVGRILCN | 681 | A8MPP1 | |
| MVCMDPLVDDNDDIL | 141 | Q9NSG2 | |
| EPLQMEDSNMEQGVE | 21 | Q8TBE0 | |
| SNDENEPETCMVEKM | 791 | P13612 | |
| EMEENRTKEPIQMDA | 601 | Q7Z4H7 | |
| VPDMMDDICQEQFLE | 256 | Q07666 | |
| EVPQMEDMILDCELN | 171 | Q8IYV9 | |
| QPEDDDRPMIDVMDQ | 776 | Q5TBA9 | |
| MPEETQTQDQPMEEE | 1 | P07900 | |
| DCQQPMLAITDPDMI | 76 | P24462 | |
| EDNNEMIPMECDSFC | 711 | Q99590 | |
| LADMFPEMNEVCQED | 441 | Q15043 | |
| MPEETQTQDQPMEEE | 1 | Q14568 | |
| ACVIQEVGMEETPLM | 121 | P01571 | |
| VPMCSDAESRQEVPM | 341 | Q96EK7 | |
| SDPNCPMEEIVRAMT | 201 | O43448 | |
| PADCLDMVAMQEAAQ | 156 | Q8N0Z8 | |
| CEANPDLIFEDMEVM | 811 | Q9H4L7 | |
| MQEDCISDIAPMQTD | 516 | O60502 | |
| PEQCLADDEITMMVP | 321 | Q8IZX4 | |
| PPEQCLSDDEITMMA | 301 | P21675 | |
| LQEMELPIMDDRACN | 191 | Q7RTY7 | |
| QPRAMMEEGEDLQSC | 231 | Q9Y6Q9 | |
| NDPEDMDLCSQMEND | 1501 | Q7Z333 | |
| METEAEMECETPNQP | 1886 | P08F94 | |
| MDPMELRNVNIEPDD | 1 | Q969I6 | |
| ECPDELIERTMMVNC | 156 | Q8IZV5 | |
| LNEEETSPQCQMDRM | 691 | Q9NZQ3 | |
| PVDEEMIMLQCTETF | 311 | Q7Z7C7 | |
| EEAILMCMEIIRQAP | 166 | Q9Y5Q9 | |
| EEMKVMCDNNPVSLN | 376 | Q8IZF2 | |
| PFMNLVIDECVEMAT | 36 | P62308 | |
| TPDMMVQERPLDVDC | 156 | Q6FHJ7 | |
| PFMNLVIDECVEMAT | 36 | A8MWD9 | |
| FVMPTEENIDRMCQD | 91 | Q8WVM8 | |
| DLEDICQQMGPMIDE | 321 | O75886 | |
| CQQMGPMIDEKLEEI | 326 | O75886 | |
| LDCELQEMDPENMLL | 31 | Q9NZQ9 | |
| DAVEMEMATVLEQCP | 296 | Q9NZQ9 | |
| QCHTLLAPEMEDNEM | 311 | Q9UET6 | |
| AEDDIQEMPENPDTM | 741 | Q86T82 | |
| DMTEEQLASAMELPC | 91 | P54578 | |
| MQTEECPPMLDATQQ | 351 | Q96SA4 | |
| VLEMVEECERRMQPD | 376 | Q9UBB9 |